Semler Research Center, in strategic collaboration with state-of-the-art, GLP compliant pre-clinical facilities, can design and implement comprehensive studies for NCEs and biologicals from lead to phase clinical studies.
Our formulation capabilities include:
In addition, we conduct toxicology studies including in vitro genetic testing (Ames, Chromosome Aberration, Micronucleus) and in vivo studies that include acute to chronic toxicity, carcinogenicity, development and reproduction studies, safety pharmacology (core battery), micro-dosing (phase 0), immuno-toxicology (core battery) and environmental risk assessment.
SRC offers top-notch scientific expertise across dosage forms and modes of administration. Our scientists have several decades of experience in developing products for US, EU, India, Brazilian, Turkish, South African & other markets across diverse therapeutic areas.
INDIA Tel: +91 80 4262 7200
US Tel: +1 818 760 1000